A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Antiviral agent 10 | Antiviral agent 10 is an antiviral agent and it can inhibit respiratory syncytial virus (RSV). Synonyms: Antiviral agent 10|Oprea1_361031|Oprea1_640984|SCHEMBL14825202|AKOS001021721|AKOS016377083|HY-142009|CS-0311654. Grade: ≥98% (HPLC). CAS No. 312615-62-6. Molecular formula: C22H24N2O5. Mole weight: 396.44. |  |
| Antiviral agent 12 | N-(1-Benzyl-4-piperidyl)adamantane-1-carboxamide inhibits Ebola virus entry into host cells by binding to surface glycoproteins, and it inhibits the Ebola virus with an EC50 of 3.9 μM. Synonyms: 314030-54-1; N-(1-benzylpiperidin-4-yl)adamantane-1-carboxamide; Antiviral agent 12; N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide; Oprea1_394577; Oprea1_833933; CHEMBL1621026; SCHEMBL19172948; EX-A4094; AKOS000671998; PD158745; TS-09814; HY-115848; CS-0369318; Z68296869. Grade: ≥95%. CAS No. 314030-54-1. Molecular formula: C6H15ClN2O2. Mole weight: 186.67. | |
| Antiviral agent 24 | N6-(3-Trifluoromethylbenzyl)adenosine is a biomedical compound in the research of diverse ailments, exhibiting remarkable potential as an adenosine receptor agonist. Its profound influence on neurotransmitter regulation renders it highly efficacious in studying neurological disorders, cardiovascular afflictions and inflammation-related conditions. Synonyms: Antiviral agent 24; 23661-03-2; N6-(3-Trifluoromethylbenzyl)adenosine; 1-(|A-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine; SCHEMBL641041; CHEMBL225766; SDQKDCSBWUSBDO-LSCFUAHRSA-N; MS-27485; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[3-(trifluoromethyl)phenyl]methylamino]purin-9-yl]oxolane-3,4-diol. Grade: ≥95%. CAS No. 23661-03-2. Molecular formula: C21H20O9. Mole weight: 416.4. | |
| Antiviral agent 5 | An intermediate in the numerous antiviral protease inhibitors is the glutamine analogue. Antiviral agent 5 is an intermediate used in antiviral agents targeting 3C and 3CL proteases including SARS-CoV-2 Mpro. Synonyms: Antiviral agent 5|CS-0227298. Grade: ≥98% (HPLC). CAS No. 2698336-82-0. Molecular formula: C18H30N2O7. Mole weight: 386.44. | |
| Antiviral agent 52 | Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It is a blood-borne virus, which can cause both acute and chronic hepatitis. CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection with EC50 of 17 nM. It displays good pharmacokinetics in mice with preferential liver distribution without significant hepatotoxicity. CAY10704 is also selective for HCV over dengue virus with EC50 of 4.62 μM. Synonyms: 101784-44-5; 1-(Bis(4-chlorophenyl)methyl)-4-methylpiperazine; Antiviral agent 52; 1-[bis(4-chlorophenyl)methyl]-4-methylpiperazine; 1-[bis(4-chlorophenyl)methyl]-4-methyl-piperazine; CAY10704; SCHEMBL2056217; CHEMBL3771316; BEA78444; AKOS040755846; HY-113860; CS-0062963. Grade: ≥98%. CAS No. 101784-44-5. Molecular formula: C18H20Cl2N2. Mole weight: 335.27. | |
| Antiviral agent 9 | Antiviral agent 9 reaches a single-digit picomolar EC50 value (0.006 nM) against HIV-1 and nearly 300-fold higher selectivity index (SI) compared to tenofovir alafenamide fumarate (TAF). Synonyms: Isopropyl (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(4-((S)-2-(((benzyloxy)carbonyl)amino)-4-cyclopentyl-3-oxobutyl)phenoxy)phosphoryl)-L-alaninate. Molecular formula: C38H50N7O8P. Mole weight: 763.82. | |
| Antiviral protein Y3 | The source of Antiviral protein Y3 is Pleurotus citrinopileatus. It has antiviral activity against Tobacco mosaic virus and antitumor activity against stomach cancer cells in vitro. | |
| Anti-virus agent 1 | Anti-virus agent 1 (compound 4i), a phosphoramidate proagent of GS-5734 (HY-104077; Remdesivir), has potent antiviral activity. Anti-virus agent 1 is used for the research of coronavirus and Ebola virus (EBOV) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Remdesivir isopropyl ester analog. CAS No. 1911578-83-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131233. |  |
| Anti-Virus Compound Library | Quantity: A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; - Target viruses include HBV, HCV, HIV, HSV, Influenza Virus, Reverse Transcriptase, etc. covering more than 140 targets; - Structurally diverse and strong bioactivity; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description, providing reference for your experimental design; - NMR and HPLC/LCMS validated to ensure high purity and quality. - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L1700. Categories: Anti-Virus Compounds Libraries. |  |
| Anti-virus Traditional Chinese Medicine Monomer Library | A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. Uses: Scientific use. Product Category: L6730. Categories: Anti-virus Traditional Chinese Medicine Monomer Libraries. | |
| Anti-VMAT2 antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. |  |
| Anti-VMAT2/SLC18A2 antibody produced in goat | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-von Willebrand Factor antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-VP16 antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-VPS34 antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-VSV-G antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-VSV-Glycoprotein?Agarose antibody, Mouse monoclonal | clone P5D4, purified from hybridoma cell culture, PBS suspension. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WAS antibody produced in chicken | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WAS antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WASF1 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WASH1 antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 1 antibody produced in rabbit | IgG fraction of antiserum, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 2 antibody produced in rabbit | IgG fraction of antiserum, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 3 antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 4 antibody produced in rabbit | lyophilized powder, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 5 antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Water Channel Aquaporin 6 antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WAVE-1 antibody produced in rabbit | ~2 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WAVE-1 (C-terminal) antibody produced in rabbit | ~1.5 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WAVE antibody produced in rabbit | ~1.5 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WIPI-2 antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Wiskott-Aldrich Syndrome/WASP antibody produced in goat | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Wnt-4 antibody produced in goat | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WRB antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WRN antibody, Mouse monoclonal | clone 195C, purified from hybridoma cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WRN antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WTX (C-terminal) antibody produced in rabbit | ~1.5 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WWOX antibody produced in mouse | purified immunoglobulin, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-WWOX antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XIAP antibody produced in goat | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XIAP antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XPA (C-terminal) antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XPB antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XPC (C-terminal) antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XPG (C-terminal) antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XRCC3 antibody produced in rabbit | affinity isolated antibody, ammonium sulfate suspension. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XRCC5 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-XTP3-B antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Y14 antibody, Mouse monoclonal | clone 4C4, purified from hybridoma cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-YAP1 (C-terminal) antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-YWHAG antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-YY1 (N-terminal) antibody produced in rabbit | Ig fraction of antiserum. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZAP70 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZBTB7A antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZDHHC17 (AB1) antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZDHHC17 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZFP36 antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZFP91 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution, Ab2. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZIC2 antibody produced in rabbit | affinity isolated antibody, ammonium sulfate suspension. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Zip Kinase antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZMAT3 antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZNF746 antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZNF746 (C-terminal region) antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-ZYX antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Zyxin antibody, Mouse monoclonal | clone ZOL301, purified from hybridoma cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Zyxin antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Ant-m7GDP | Ant-m7GDP is an exceptional pharmacological compound characterized by its profound capacity to combat viral infections. This awe-inspiring compound exhibits an unparalleled proclivity for selectively targeting and disrupting the intricate guanosine triphosphate cap structures, thereby impeding the vital process of viral mRNA capping. Synonyms: 2'/3'-O-Anthraniloyl-7-methylguanosine-5'-diphosphate, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C18H22N6O12P2 (free acid). Mole weight: 576.35 (free acid). | |
| Ant-m7GMP | Ant-m7GMP is a biomedical compound used for the research of RNA-related diseases specifically targeting RNA molecules with the modified nucleotide 7-methylguanosine. By inhibiting the function of these modified RNA molecules, ant-m7GMP offers potential in studying conditions such as cancer, viral infections and neurological disorders. Synonyms: 2'/3'-O-Anthraniloyl-7-methylguanosine-5'-monophosphate, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C18H21N6O9P (free acid). Mole weight: 496.37 (free acid). | |
| Ant-m7GTP | Ant-m7GTP is a crucial tool used to study mRNA splicing and translation. It assists in investigating cellular processes and protein research. By targeting modified nucleotides in the mRNA cap structure is ant-m7GTP aids in understanding diseases like cancer and viral infections, enhancing drug discovery and development efforts. Synonyms: 2'/3'-O-Anthraniloyl-7-methylguanosine-5'-triphosphate, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C18H24N6O15P3 (free acid). Mole weight: 656.33 (free acid). | |
| Antofloxacin | Antofloxacin is an orally active and broad-spectrum 8-amino-fluoroquinolone with potent antibacterial activities. Antofloxacin shows superior antibacterial activity against gyrA mutation-positive H. pylori strains, especially in Asn87- mutated strains, compared to levofloxacin. Uses: Anti-bacterial agents. Synonyms: (S)-Antofloxacin; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 8-amino-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-. CAS No. 119354-43-7. Molecular formula: C18H21FN4O4. Mole weight: 376.38. | |
Our database is helping our users find suppliers everyday.
